Latest Revenue Generation News

SportsHero Limited has secured a major content deal with Playades, adding over 400 popular mobile games to its HeroPlay platform and boosting subscriber growth in Southeast Asia ahead of the FIFA World Cup 2026.

Metallium Limited’s US subsidiary has inked a decade-long off-take agreement with Indium Corporation, setting a firm commercial foundation for supplying critical metals like gallium and germanium recovered through innovative recycling technology.

Papyrus Australia has commissioned its Adelaide Rapid Prototyping & R&D Facility, marking a key step in validating its pulp technology and progressing towards commercial production. The company also released its interim financials and reported stable cash flow supporting ongoing operations.

Cyclopharm Limited is rapidly expanding its Technegas® lung imaging technology across the US, securing new contracts and advancing clinical guideline recognition that could boost adoption.

WA Kaolin Limited has announced a partially underwritten pro-rata rights offer to raise up to $34.9 million, aiming to reduce debt and provide working capital to stabilise its Wickepin kaolin operations amid ongoing ASX suspension.

RocketBoots has secured a significant A$3.3 million activation contract with a leading multinational retailer, marking the start of a global deployment phase that complements its existing SaaS agreement and promises near-term revenue growth.

EV Resources has begun refurbishing its Tecomatlán Processing Plant in Mexico, marking a pivotal shift from exploration to near-term antimony production amid tightening global supply. The company aims to leverage this low-cost, staged approach to secure a first mover advantage in the critical minerals market.

Oneview Healthcare PLC has launched a Security Purchase Plan (SPP) to raise up to A$2 million, following a recent A$19 million placement. The SPP offers eligible shareholders discounted shares to support AI development and customer deployments.

Emyria Limited is on track to open its first Empax clinic in Victoria by Q2 2026, having secured key operational milestones including a trained clinical workforce and dual reimbursement pathways.

Echo IQ has strengthened its partnership with Mayo Clinic to distribute its AI-driven heart failure diagnostic tool, EchoSolv HF, pending FDA clearance. The expanded agreement offers a scalable commercial pathway across a vast US hospital network.

Aguia Resources has completed the sale of its non-core Atocha Silver Project in Colombia, receiving the final C$1 million cash payment and fully divesting its interest. This move reflects a strategic shift to focus on near-term production assets and strengthens the company’s balance sheet.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.